Total Payments
$2,796
2024 Payments
$1,100
Companies
12
Transactions
96
Payment Breakdown by Category
Food & Beverage$2,776 (99.3%)
Education$20.25 (0.7%)
Payments by Nature
| Nature of Payment | Amount | Transactions | Share |
|---|---|---|---|
| Food and Beverage | $2,776 | 94 | 99.3% |
| Education | $20.25 | 2 | 0.7% |
Top Paying Companies
| Company | Total | Records | Latest Year |
|---|---|---|---|
| Novo Nordisk Inc | $1,023 | 31 | $0 (2024) |
| Salix Pharmaceuticals, a division of Bausch Health US, LLC | $307.16 | 12 | $0 (2024) |
| IDORSIA PHARMACEUTICALS US INC | $299.45 | 11 | $0 (2024) |
| ABBVIE INC. | $295.87 | 11 | $0 (2024) |
| Merck Sharp & Dohme LLC | $235.55 | 6 | $0 (2024) |
| Amgen Inc. | $201.29 | 9 | $0 (2024) |
| GlaxoSmithKline, LLC. | $145.34 | 2 | $0 (2023) |
| Novartis Pharmaceuticals Corporation | $93.65 | 4 | $0 (2024) |
| PFIZER INC. | $84.94 | 4 | $0 (2024) |
| Lilly USA, LLC | $61.65 | 3 | $0 (2024) |
Payment History by Year
| Year | Amount | Transactions | Top Company |
|---|---|---|---|
| 2024 | $1,100 | 49 | Novo Nordisk Inc ($289.13) |
| 2023 | $984.24 | 36 | IDORSIA PHARMACEUTICALS US INC ($274.45) |
| 2022 | $471.11 | 9 | Novo Nordisk Inc ($380.75) |
| 2019 | $240.69 | 2 | Merck Sharp & Dohme Corporation ($123.04) |
All Payment Transactions
96 individual payment records from CMS Open Payments — Page 1 of 4
| Date | Company | Product | Nature | Form | Amount | Type |
|---|---|---|---|---|---|---|
| 12/16/2024 | Novo Nordisk Inc | Ozempic (Drug), Rybelsus | Food and Beverage | In-kind items and services | $13.10 | General |
| Category: Diabetes | ||||||
| 12/11/2024 | Merck Sharp & Dohme LLC | GARDASIL (Biological), CAPVAXIVE, GARDASIL 9 | Food and Beverage | In-kind items and services | $23.35 | General |
| Category: VACCINE | ||||||
| 12/10/2024 | ABBVIE INC. | SYNTHROID (Drug) | Food and Beverage | In-kind items and services | $31.41 | General |
| Category: IMMUNOLOGY | ||||||
| 12/02/2024 | Novo Nordisk Inc | Rybelsus (Drug), Ozempic | Food and Beverage | In-kind items and services | $27.47 | General |
| Category: Diabetes | ||||||
| 11/25/2024 | Novo Nordisk Inc | Rybelsus (Drug), Ozempic | Food and Beverage | In-kind items and services | $10.62 | General |
| Category: Diabetes | ||||||
| 11/22/2024 | ABBVIE INC. | CREON (Drug), LINZESS | Food and Beverage | In-kind items and services | $24.29 | General |
| Category: ENDOCRINOLOGY | ||||||
| 11/21/2024 | PFIZER INC. | NURTEC ODT (Drug), ZAVZPRET | Food and Beverage | In-kind items and services | $23.32 | General |
| Category: PAIN | ||||||
| 11/01/2024 | Salix Pharmaceuticals, a division of Bausch Health US, LLC | XIFAXAN (Drug) | Food and Beverage | In-kind items and services | $15.90 | General |
| Category: Gastroenterology | ||||||
| 10/31/2024 | Novo Nordisk Inc | Ozempic (Drug), Rybelsus | Food and Beverage | In-kind items and services | $32.49 | General |
| Category: Diabetes | ||||||
| 10/24/2024 | Novo Nordisk Inc | Rybelsus (Drug), Ozempic | Food and Beverage | In-kind items and services | $10.55 | General |
| Category: Diabetes | ||||||
| 10/21/2024 | Amgen Inc. | Otezla (Drug), Repatha | Food and Beverage | In-kind items and services | $21.71 | General |
| Category: Inflammation | ||||||
| 10/19/2024 | Novo Nordisk Inc | Ozempic (Drug), Rybelsus | Food and Beverage | In-kind items and services | $23.92 | General |
| Category: Diabetes | ||||||
| 10/09/2024 | ABBVIE INC. | CREON (Drug), LINZESS | Food and Beverage | In-kind items and services | $32.49 | General |
| Category: ENDOCRINOLOGY | ||||||
| 10/03/2024 | Merck Sharp & Dohme LLC | GARDASIL (Biological), CAPVAXIVE, GARDASIL 9 | Food and Beverage | In-kind items and services | $32.01 | General |
| Category: VACCINE | ||||||
| 09/30/2024 | Novo Nordisk Inc | Ozempic (Drug), Rybelsus | Food and Beverage | In-kind items and services | $7.19 | General |
| Category: Diabetes | ||||||
| 09/26/2024 | ABBVIE INC. | SYNTHROID (Drug) | Food and Beverage | In-kind items and services | $25.08 | General |
| Category: IMMUNOLOGY | ||||||
| 09/23/2024 | Amgen Inc. | Otezla (Drug), Repatha | Food and Beverage | In-kind items and services | $22.31 | General |
| Category: Inflammation | ||||||
| 09/19/2024 | Novo Nordisk Inc | Ozempic (Drug), Rybelsus | Food and Beverage | In-kind items and services | $26.43 | General |
| Category: Diabetes | ||||||
| 09/13/2024 | Novartis Pharmaceuticals Corporation | LEQVIO (Drug) | Food and Beverage | In-kind items and services | $15.82 | General |
| Category: Cardiology/Vascular Diseases | ||||||
| 09/10/2024 | ABBVIE INC. | CREON (Drug), LINZESS | Food and Beverage | In-kind items and services | $24.27 | General |
| Category: ENDOCRINOLOGY | ||||||
| 09/06/2024 | Novo Nordisk Inc | Ozempic (Drug), Rybelsus | Food and Beverage | In-kind items and services | $33.58 | General |
| Category: Diabetes | ||||||
| 09/04/2024 | Salix Pharmaceuticals, a division of Bausch Health US, LLC | XIFAXAN (Drug) | Food and Beverage | In-kind items and services | $19.12 | General |
| Category: Gastroenterology | ||||||
| 08/21/2024 | Novo Nordisk Inc | Ozempic (Drug), Rybelsus | Food and Beverage | In-kind items and services | $5.71 | General |
| Category: Diabetes | ||||||
| 08/14/2024 | Novartis Pharmaceuticals Corporation | LEQVIO (Drug) | Food and Beverage | In-kind items and services | $28.87 | General |
| Category: Cardiology/Vascular Diseases | ||||||
| 08/13/2024 | ABBVIE INC. | CREON (Drug), LINZESS | Food and Beverage | In-kind items and services | $33.64 | General |
| Category: ENDOCRINOLOGY | ||||||
About Dr. George Lombardi, M.D
Dr. George Lombardi, M.D is a Infectious Disease healthcare provider based in New York, New York. This provider has been registered with the National Plan and Provider Enumeration System (NPPES) since 03/12/2007. The National Provider Identifier (NPI) number assigned to this provider is 1619009800.
According to the Centers for Medicare & Medicaid Services (CMS) Open Payments database, Dr. George Lombardi, M.D has received a total of $2,796 in payments from pharmaceutical and medical device companies, with $1,100 received in 2024. These payments were reported across 96 transactions from 12 companies. The most common payment nature is "Food and Beverage" ($2,776).
Ad
Practice Information
- Specialty Infectious Disease
- Location New York, NY
- Active Since 03/12/2007
- Last Updated 04/06/2024
- Taxonomy Code 207RI0200X
- Entity Type Individual
- Practice Solo Practitioner
- NPI Number 1619009800
Products in Payments
- Ozempic (Drug) $417.97
- XIFAXAN (Drug) $307.16
- QUVIVIQ (Drug) $299.45
- Rybelsus (Drug) $236.98
- Otezla (Drug) $165.22
- AREXVY (Drug) $124.73
- ZINPLAVA (Biological) $123.04
- Saxenda (Drug) $117.65
- CREON (Drug) $114.69
- LEQVIO (Drug) $93.65
- SYNTHROID (Drug) $76.63
- NURTEC ODT (Drug) $63.64
- GARDASIL (Biological) $55.36
- VIBERZI (Drug) $54.60
- LINZESS (Drug) $49.95
- MOUNJARO (Drug) $49.94
- GARDASIL 9 (Biological) $39.85
- Repatha (Biological) $36.07
- FARXIGA (Drug) $33.64
- PAXLOVID (Drug) $21.30
Explore
Data Sources
Provider data from NPPES. Payment data from CMS Open Payments. Medicare data from CMS Medicare Provider Utilization. All data is public and updated periodically.
Infectious Disease Doctors in New York
Sian Jones, Md, MD
Infectious Disease — Payments: $349,236
Infectious Disease $349,236
Dr. David Bekhor, Md, MD
Infectious Disease — Payments: $309,279
Infectious Disease $309,279
Genovefa Papanicolaou, Md, MD
Infectious Disease — Payments: $183,179
Infectious Disease $183,179
Dr. Michelle Cespedes, M.d, M.D
Infectious Disease — Payments: $136,443
Infectious Disease $136,443
Mr. Jose Cortes, M.d, M.D
Infectious Disease — Payments: $123,792
Infectious Disease $123,792
Dr. Martin Markowitz, Md, MD
Infectious Disease — Payments: $112,821
Infectious Disease $112,821